Very helpful Bear!
What is your expectation about Apabetalone being accepted for ASN late breaking presentation? Although AHA accepted us, that was for a Phase 3 trial. ASN on the other hand is looking at a sub study of a trial. Does that change the perception of ASN's willingness to accept our presentation?
If ASN does not accept RVX, can the same data be dumped on the AHA? I note that we only have 8 minutes to make our case at the AHA.
